Biomedical engineers set the foundation for a ground-breaking treatment regimen for treating ventricular arrhythmia. The study demonstrates the design and feasibility of a new hydrogel-based pacing modality. The scientific advance is significant considering pain management is highly relevant to overall wellness for patients with heart, lung, and blood diseases. Such innovation in painless defibrillation and preventing arrhythmia could revolutionize cardiac rhythm management.